LABOTEX
ActiveSummary
LABOTEX has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €219,305 and a net result of €14,976. Equity is growing by about 5.4% per year across the filed financial years. Its solvency ranks better than 56% of 781 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
03-07
NBB filing
Annual accounts filed
financial year 2025 · full format
2025
10-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
31-12
Financial
Equity above €200,000equity €204,329 ▲7.1%
A profit in every financial year since 2018 builds equity to €204,329.
11-07
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
31-12
Financial
Highest result from 2018 to 2025net €28,523 ▲21.7%
Operating result €41,429, net result €28,523, both a record.
30-06
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
30-06
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
29-06
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
13-07
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2019
31-12
Financial
Equity above €150,000equity €157,195 ▲7%
A profit in every financial year since 2018 builds equity to €157,195.
02-09
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format · 33 days late
2018
11-07
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
19-07
NBB filing
Annual accounts filed
financial year 2016 · full format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 18 annual accounts filed, the latest 10 are here; all 18 are under Financials.
0 of 12 deeds read
About the unread acts
We know of 12 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.